Sata M - Search Results

1

Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.

Kin M, Torimura T, Ueno T, Nakamura T, Ogata R, Sakamoto M, Tamaki S, Sata M. Kin M, et al. Among authors: sata m. Int J Oncol. 2000 Feb;16(2):375-82. doi: 10.3892/ijo.16.2.375. Int J Oncol. 2000. PMID: 10639583

2

Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.

Ueno T, Hashimoto O, Sugawara H, Ogata R, Kusaba N, Torimura T, Sata M, Tanikawa K. Ueno T, et al. Among authors: sata m. Int J Oncol. 1998 Aug;13(2):297-303. doi: 10.3892/ijo.13.2.297. Int J Oncol. 1998. PMID: 9664125

3

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, Hashimoto O, Sugawara H, Tanikawa K. Torimura T, et al. Among authors: sata m. Hum Pathol. 1998 Sep;29(9):986-91. doi: 10.1016/s0046-8177(98)90205-2. Hum Pathol. 1998. PMID: 9744316

4

OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats.

Ueno T, Sujaku K, Tamaki S, Ogata R, Kin M, Nakamura T, Sakamoto M, Torimura T, Mitsuyama K, Sakisaka S, Sata M, Tanikawa K. Ueno T, et al. Among authors: sata m. Int J Mol Med. 1999 May;3(5):497-503. doi: 10.3892/ijmm.3.5.497. Int J Mol Med. 1999. PMID: 10202181

5

Bright loop appearance; a characteristic ultrasonography sign of early hepatocellular carcinoma.

Ogata R, Majima Y, Tateishi Y, Kuromatsu R, Shimauchi Y, Torimyra T, Tanaka M, Kumashiro R, Kojiro M, Sata M. Ogata R, et al. Among authors: sata m. Oncol Rep. 2000 Nov-Dec;7(6):1293-8. doi: 10.3892/or.7.6.1293. Oncol Rep. 2000. PMID: 11032932 Clinical Trial.

6

Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.

Ueno T, Hashimoto O, Kimura R, Torimura T, Kawaguchi T, Nakamura T, Sakata R, Koga H, Sata M. Ueno T, et al. Among authors: sata m. Int J Oncol. 2001 Jan;18(1):49-55. doi: 10.3892/ijo.18.1.49. Int J Oncol. 2001. PMID: 11115538

7

Vitronectin in liver disorders: biochemical and immunohistochemical studies.

Inuzuka S, Ueno T, Torimura T, Tamaki S, Sakata R, Sata M, Yoshida H, Tanikawa K. Inuzuka S, et al. Among authors: sata m. Hepatology. 1992 Apr;15(4):629-36. doi: 10.1002/hep.1840150413. Hepatology. 1992. PMID: 1372581

8

The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis.

Torimura T, Ueno T, Inuzuka S, Kin M, Ohira H, Kimura Y, Majima Y, Sata M, Abe H, Tanikawa K. Torimura T, et al. Among authors: sata m. J Hepatol. 1994 Jul;21(1):37-46. doi: 10.1016/s0168-8278(94)80134-7. J Hepatol. 1994. PMID: 7963419 Clinical Trial.

9

A patient with hepatic granuloma formation and angiotensin-converting enzyme production by granuloma cells during clinical relapse of hepatitis A.

Inuzuka S, Ueno T, Tateishi H, Torimura T, Sata M, Tanikawa K, Kojiro M. Inuzuka S, et al. Among authors: sata m. Pathol Int. 1994 May;44(5):391-7. doi: 10.1111/j.1440-1827.1994.tb02940.x. Pathol Int. 1994. PMID: 8044309

10

Bacterial infection in cirrhosis, with and without hepatocellular carcinoma.

Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K. Yoshida H, et al. Among authors: sata m. Am J Gastroenterol. 1993 Dec;88(12):2067-71. Am J Gastroenterol. 1993. PMID: 8249975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,459 results

Search Page

Filters